|本期目录/Table of Contents|

[1]周玉霞,姚晓文,王蓉,等.新型冠状病毒肺炎感染两性差别研究进展[J].医学研究与战创伤救治(原医学研究生学报),2022,24(2):187-190.[doi:10.3969/j.issn.1672-271X.2022.02.016]
　ZHOU Yu-xia,YAO Xiao-wen,WANG Rong,et al.Research progress on gender differences under novel coronavirus pneumonia[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(2):187-190.[doi:10.3969/j.issn.1672-271X.2022.02.016]
点击复制

新型冠状病毒肺炎感染两性差别研究进展()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第24卷
期数:
2022年2期
页码:
187-190
栏目:
综述
出版日期:
2022-03-20

文章信息/Info

Title:
Research progress on gender differences under novel coronavirus pneumonia
作者:
周玉霞; 姚晓文; 王蓉; 张久聪
作者单位：730030兰州，甘肃中医药大学第一临床医学院（周玉霞、姚晓文、王蓉）；730050兰州，解放军联勤保障部队第九四○医院消化内科（张久聪）
Author(s):
ZHOU Yu-xia; YAO Xiao-wen; WANG Rong ; ZHANG Jiu-cong
(1. The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou 730030, Gansu, China; 2.Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Force of PLA, Lanzhou 730050, Gansu, China)
关键词:
新型冠状病毒肺炎; 性别差异; 肾素-血管紧张素系统; 血管紧张素转换酶-2; 细胞因子风暴
Keywords:
novel coronavirus pneumonia;  gender difference;  renin-angiotensin-system;  angiotensin-convertion enzyme-2;  cytokine storm
分类号:
R18
DOI:
10.3969/j.issn.1672-271X.2022.02.016
文献标志码:
A
摘要:
新型冠状病毒肺炎由于其极强的传染力目前仍在全球范围内广泛流行，对人们的生命健康造成了极大威胁。然而，通过查阅研究既往文献资料发现，在感染率、危重状况和死亡率上存在性别上的差异。比起女性，男性在新冠肺炎中更容易被感染且病情更严重死亡率更高。首先，性别会对肾素-血管紧张素系统（RAS系统）中的关键成分血管紧张素转换酶-2的表达产生影响，这可能使两性在新冠肺炎的表现中产生差异。其次，由于女性有着积极快速强烈的免疫反应，而男性在遇到病原体时免疫反应相对处于弱势，这可能也是新冠肺炎下产生性别差异的原因之一。文章主要从RAS系统失衡和细胞因子风暴这两个新冠肺炎致病因素来对造成性别差异的潜在作用机制研究进展进行综述。
Abstract:
The outbreak of COVID-19 in December 2019 poses a great threat to people’s lives and health because of its strong infectivity, which is still widespread worldwide. However, interestingly, by consulting previous literature, we found that there are gender differences ininfection rate, critical condition and mortality. Compared with women, men are more likely to be infected in novel coronavirus pneumonia and have higher mortality. First of all, gender will affect the expression of angiotensin converting enzyme-2 (ACE2), a key component in the renin-angiotensin system (RAS system), which may lead to gender differences in the performance of novel coronavirus pneumonia. Secondly, because women have a positive, rapid and potent immune response, and men have a relatively weak immune response when encountering pathogens, this may also be one of the reasons for gender differences under novel coronavirus pneumonia. In this review, we briefly analyze the research progress in the hypothetical mechanism of gender differences from the two pathogenic factors of novel coronavirus pneumonia, RAS system imbalance and cytokine storm.

参考文献/References:

[1]Mohamed MS, Moulin TC, Schith HB. Sex differences in COVID-19: the role of androgens in disease severity and progression [J].Endocrine,2021, 71(1):3-8.
[2]Wolfe J, Safdar B, Madsen TE, et al. Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2[J]. Clin Ther, 2021,43(3):557-571.
[3]赵承奇,靳增华,王雪芬,等.新型冠状病毒肺炎治疗药物的研究进展[J].东南国防医药,2021, 23(1):58-63.
[4Mungroo MR, Khan NA, Siddiqui R. The increasing importance of the novel Coronavirus[J]. Hosp Pract (1995),2021, 49(1):1-11.
[5]Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: are males more vulnerable [J].Biol Sex Differ,2020,11(1):53.
[6]Xie M, Chen Q. Insight into 2019 novel coronavirus-An updated interim review and lessons from SARS-CoV and MERS-CoV [J].Int J Infect Dis, 2020,94:119-124.
[7]Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis [J].Trends Immunol, 2020,41(12):1100-1115.
[8]Tsai SC, Lu CC, Bau DT, et al. Approaches towards fighting the COVID-19 pandemic (Review) [J].Int J Mol Med, 2021, 47(1):3-22.
[9]Asselah T, Durantel D, Pasmant E, et al.COVID-19: Discovery, diagnostics and drug development [J].J Hepatol,2021, 74(1):168-184.
[10]傅点,王玉,李傲梅,等.新型冠状病毒肺炎患者慢性基础疾病的治疗管理[J].医学研究生学报,2020, 33(9):974-976.
[11]Lanza K, Perez LG, Costa LB, et al. Covid-19: the renin-angiotensin system imbalance hypothesis. [J].Clin Sci (Lond),2020, 134(11):1259-1264.
[12]Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resulting ARDS [J]. Postgrad Med J,2020, 96(1137):403-407.
[13]Verdecchia P, Cavallini C, Spanevello A, et al. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection [J].Eur J Intern Med,2020, 76:14-20.
[14]Saad MI, McLeod L, Hodges C, et al. ADAM17 Deficiency Protects against Pulmonary Emphysema [J]. Am J Respir Cell Mol Biol,2021, 64(2):183-195.
[15]Wu J, Deng W, Li S, et al. Advances in research on ACE2 as a receptor for 2019-nCoV[J]. Cell Mol Life Sci,2021, 78(2):531-544.
[16]Kim JS, Lee JY, Yang JW, et al. Immunopathogenesis and treatment of cytokine storm in COVID-19 [J].Theranostics,2021, 11(1):316-329.
[17]Ragab D, Salah Eldin H, Taeimah M, et al.The COVID-19 Cytokine Storm; What We Know So Far [J].Front Immunol, 2020,11:1446.
[18]Luo XH, Zhu Y, Mao J, et al.T cell immunobiology and cytokine storm of COVID-19 [J].Scand J Immunol,2021,93(3):e12989.
[19]Hu B, Huang S, Yin L. The cytokine storm and COVID-19 [J]. J Med Virol,2021, 93(1):250-256.
[20]Gustine JN, Jones D. Immunopathology of Hyperinflammation in COVID-19 [J].Am J Pathol, 2021, 191(1):4-17.
[21]Sharma RK, Li J, Krishnan S, et al.Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases [J]. Clin Sci (Lond),2021, 135(1):1-17.
[22]Bourgonje AR, Abdulle AE, Timens W,et al.Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)[J]. J Pathol, 2020, 251(3):228-248.
[23]McGuire BB, Watson RW, Pérez-Barriocanal F, et al.Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney [J]. Kidney Blood Press Res, 2007,30(2):67-80.
[24]Gargaglioni LH, Marques DA. Let’s talk about sex in the context of COVID-19[J]. J Appl Physiol (1985), 2020,128(6):1533-1538.
[25]Moradi F, Enjezab B, Ghadiri-Anari A. The role of androgens in COVID-19 [J].Diabetes Metab Syndr,2020,14(6):2003-2006.
[26]Viveiros A, Rasmuson J, Vu J,et al. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones[J]. Am J Physiol Heart Circ Physiol,2021,320(1):H296-H304.

相似文献/References:

[1]沈国栋,谭伟龙.新型冠状病毒肺炎流行期间军队医疗机构面临的采供血和输血风险与安全防护[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):342.[doi:10.3969/j.issn.1672-271X.2020.04.002]
　SHEN Guo-dong,TAN Wei-long.Risk and safety of blood collection and transfusion in military medical institutions during COVID-19 epidemic[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(2):342.[doi:10.3969/j.issn.1672-271X.2020.04.002]
[2]杨艳,王佳佳,汪文妮,等.新型冠状病毒肺炎期间军队医院老年病房的防控管理[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):434.[doi:10.3969/j.issn.1672-271X.2020.04.024]
[3]郑翠霞,崔绘丽,吴栋云,等.新型冠状病毒肺炎恢复期血浆治疗对重型患者活动耐力的影响[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):487.[doi:10.3969/j.issn.1672-271X.2020.05.008]
　ZHENG Cui-xia,7,CUI Hui-li,et al.Novel coronavirus pneumonia recovery plasma treatment on heavy patient’s activity endurance influence[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(2):487.[doi:10.3969/j.issn.1672-271X.2020.05.008]
[4]王颖,钟勇,金涛,等.新型冠状病毒肺炎期间做好军队老干部防疫工作的实践与思考[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):552.[doi:10.3969/j.issn.1672-271X.2020.05.026]
[5]陈伟,施涛,王少华,等.新型冠状病毒肺炎疫情期间医院发热诊区的军队人员管理实践[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):555.[doi:10.3969/j.issn.1672-271X.2020.05.027]
[6]金娥,陈珺,陈丽珍,等.新型冠状病毒肺炎疫情期间血液净化室防控实践[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):558.[doi:10.3969/j.issn.1672-271X.2020.05.028]
[7]周莉萍,黄迎春,浦嘉丽,等.思维导图在新型冠状病毒肺炎疫情期间辅助护士优化预检筛查流程中的应用[J].医学研究与战创伤救治(原医学研究生学报),2020,22(6):658.[doi:10.3969/j.issn.1672-271X.2020.06.023]
[8]袁力,陈醒,孙伟,等.援鄂医疗队在抗击新型冠状病毒肺炎中的药品保障实践与思考[J].医学研究与战创伤救治(原医学研究生学报),2020,22(6):661.[doi:10.3969/j.issn.1672-271X.2020.06.024]
[9]刘颖,伏海燕,李美玲,等.新型冠状病毒肺炎疫情期间医院生殖中心防控管理探讨[J].医学研究与战创伤救治(原医学研究生学报),2020,22(6):664.[doi:10.3969/j.issn.1672-271X.2020.06.025]
[10]赵承奇,靳增华,王雪芬,等.新型冠状病毒肺炎治疗药物的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):58.[doi:10.3969/j.issn.1672-271X.2021.01.001]
　ZHAO Cheng-qi,JIN Zeng-hua,WANG Xue-fen,et al.Currentstatus andadvances for development of drugs to treat coronavirus disease 2019[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(2):58.[doi:10.3969/j.issn.1672-271X.2021.01.001]

备注/Memo

备注/Memo:
基金项目：火神山医院科研基金（HSS-217）；联勤保障部队第九四○医院院内基金（20yjky020）
更新日期/Last Update: 2022-04-18